Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 295 articles:
HTML format



Single Articles


    February 2026
  1. JI Y, Li P, Liu Y, Shen D, et al
    Persistent Gene Activation as a Molecular Signature of Ulcerative Colitis Progression to Colorectal Cancer.
    Dig Dis Sci. 2026 Feb 20. doi: 10.1007/s10620-026-09742.
    PubMed     Abstract available


  2. ODAH T, Deceus F, Tamim H, Farraye FA, et al
    Crohn's Disease-Related Abdominal and Pelvic Abscesses: Treatment Patterns and Outcomes.
    Dig Dis Sci. 2026 Feb 19. doi: 10.1007/s10620-026-09751.
    PubMed     Abstract available


  3. WONG ECL, Dulai PS, Marshall JK, Jairath V, et al
    Impact of Comorbid Psoriasis on the Efficacy of Ustekinumab and Mirikizumab in Inflammatory Bowel Disease: A Post-hoc Analysis of UNITI, SEAVUE, and LUCENT.
    Dig Dis Sci. 2026 Feb 19. doi: 10.1007/s10620-026-09752.
    PubMed     Abstract available


  4. KELLERMAYER R, Szigeti RG, Sammer M, Vogel AM, et al
    Type 1 Dolichocolon as a Potential Anatomic Co-morbidity in Children with Perianal Crohn's Disease.
    Dig Dis Sci. 2026 Feb 18. doi: 10.1007/s10620-026-09759.
    PubMed     Abstract available


  5. AHUJA D, Choi J, Zou G, Goodwin SW, et al
    Impact of Age on Efficacy and Safety of Advanced Therapies During Induction in Ulcerative Colitis: An Individual Patient Data Pooled Analysis from Randomized Controlled Trials.
    Dig Dis Sci. 2026 Feb 16. doi: 10.1007/s10620-026-09753.
    PubMed     Abstract available


  6. SHLOMO Y, Lital B, Ofra C, Yehudit C, et al
    Effect of Perianal Disease on Quality of Life, Fecal Incontinence, and Sexual Function in Patients with Crohn's Disease.
    Dig Dis Sci. 2026 Feb 16. doi: 10.1007/s10620-026-09766.
    PubMed     Abstract available


  7. IBRAHIM A, Rockey DC
    Clinical Outcomes in Patients with Primary Sclerosing Cholangitis With and Without Inflammatory Bowel Disease.
    Dig Dis Sci. 2026 Feb 6. doi: 10.1007/s10620-026-09699.
    PubMed     Abstract available


  8. VERNON-ROBERTS A, Day AS
    Concise Commentary: Caregiver Contributions to Self-Care Among Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2026 Feb 4. doi: 10.1007/s10620-026-09716.
    PubMed    


    January 2026
  9. CHANG LK, Liao CY, Lin WC, Lee CY, et al
    Incidental Appendiceal Mucocele in a Patient with Ulcerative Colitis.
    Dig Dis Sci. 2026 Jan 31. doi: 10.1007/s10620-026-09702.
    PubMed    


  10. DING Z, Tang G, Yan Y, Yang Y, et al
    A Case of Ulcerative Colitis Combined with Pulmonary Air Leak Syndrome.
    Dig Dis Sci. 2026 Jan 28. doi: 10.1007/s10620-026-09671.
    PubMed    


  11. MCSHANE C, O'Connell F, Kevans D, O'Sullivan J, et al
    Ex Vivo Human Colonic Explants Identify Metabolic Alterations and Cytokine Dysregulation in Ulcerative Colitis: A Pilot Study.
    Dig Dis Sci. 2026 Jan 26. doi: 10.1007/s10620-025-09665.
    PubMed     Abstract available


  12. TOLU T, Kani HT
    Beyond Adiposity: Lean Mass Phenotyping and Adipokine Interpretation in Pediatric Crohn's Disease.
    Dig Dis Sci. 2026 Jan 22. doi: 10.1007/s10620-026-09681.
    PubMed    


  13. HOLTEN KIA, Bernklev T, Opheim R, Olsen BC, et al
    Fatigue Trajectory During the First Year of an Inflammatory Bowel Disease Diagnosis, Results from the IBSEN III study.
    Dig Dis Sci. 2026 Jan 12. doi: 10.1007/s10620-025-09661.
    PubMed     Abstract available


  14. MOHAMED MFH, Gupta SR, Beran A, Hamid O, et al
    Pneumococcal Vaccine Is Associated with Improved Outcomes in Inflammatory Bowel Disease: Insights from a Propensity-Matched Study in the United States.
    Dig Dis Sci. 2026 Jan 10. doi: 10.1007/s10620-025-09653.
    PubMed     Abstract available


  15. ALI MP, West RL, Duijvestein M, van der Woude CJ, et al
    Implementation of Outcome-Based Quality Improvement in Dutch Inflammatory Bowel Disease Centres.
    Dig Dis Sci. 2026 Jan 9. doi: 10.1007/s10620-025-09636.
    PubMed     Abstract available


  16. ZHOU P, Zhang K, Pan H, Wang J, et al
    High Complexity Anal Fistula in Perianal Fistula Crohn's Disease with Rectal Fistula.
    Dig Dis Sci. 2026 Jan 9. doi: 10.1007/s10620-025-09664.
    PubMed    


  17. CASTILLO G, Beaty W, Delau O, Sultan K, et al
    Longitudinal Study of Sexual Dysfunction in Men and Women with Inflammatory Bowel Disease Initiating Biologic or Small Molecule Therapy.
    Dig Dis Sci. 2026 Jan 8. doi: 10.1007/s10620-025-09652.
    PubMed     Abstract available


  18. VAN LIEROP LMA, Hoentjen F
    Extending Knowledge: The Case for Treat-to-Target Management in Patients with Ulcerative Colitis Who Fail Early Treatment.
    Dig Dis Sci. 2026 Jan 8. doi: 10.1007/s10620-025-09662.
    PubMed    


  19. GARCIA NM, Memel Z, Zou Y, Thiemann A, et al
    Upadacitinib Is Safe and Effective in Older Adults: A Real-World Experience Comparing Safety and Efficacy in Younger Versus Older Adults with Inflammatory Bowel Disease.
    Dig Dis Sci. 2026 Jan 5. doi: 10.1007/s10620-025-09647.
    PubMed     Abstract available


  20. DEVI J, Jena A, Hassan A, Lohia R, et al
    Response to Correspondence on Global Training in Inflammatory Bowel Disease.
    Dig Dis Sci. 2026 Jan 3. doi: 10.1007/s10620-025-09628.
    PubMed     Abstract available


  21. BARTLETT R, Mohamedrashed M, Yogakanthi S, Chew M, et al
    Trends in Length of Stay, Steroid Use and Colectomy Rates in Patients Admitted with Acute Severe Ulcerative Colitis: The Impact of Accelerated and Intensified Infliximab Dosing.
    Dig Dis Sci. 2026 Jan 3. doi: 10.1007/s10620-025-09635.
    PubMed     Abstract available


  22. CHANG A, Shahrvini B, Oh J, Prajapati DP, et al
    Increased Autoimmunity Burden Is a Risk Factor for Developing Irritable Bowel Syndrome-Like Symptoms in Quiescent Inflammatory Bowel Disease.
    Dig Dis Sci. 2026 Jan 3. doi: 10.1007/s10620-025-09633.
    PubMed     Abstract available


    December 2025
  23. PARK SJ, Park SW, Cheon JH
    Ten-Year Trend in 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients with Ulcerative Colitis: An Analysis of Korean Health Insurance Data.
    Dig Dis Sci. 2025 Dec 23. doi: 10.1007/s10620-025-09629.
    PubMed     Abstract available


  24. GILMORE R, Tambakis G
    Intestinal Ultrasound for Inflammatory Bowel Disease: The Sound at the End of the Tunnel?
    Dig Dis Sci. 2025 Dec 20. doi: 10.1007/s10620-025-09623.
    PubMed    


  25. RAMESH PR, Hartman RP, Harmsen WS, Klug J, et al
    Evaluating the Impact of Visceral Adiposity and Sarcopenia on Outcomes in Hospitalized Patients with Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2025 Dec 19. doi: 10.1007/s10620-025-09596.
    PubMed     Abstract available


  26. GADE A, Saraga A, Deyhim T, Geeganage G, et al
    Proactive Compared to Reactive Therapeutic Drug Monitoring Is Associated with Less Treatment Failure in Patients with Inflammatory Bowel Disease Treated with Adalimumab.
    Dig Dis Sci. 2025 Dec 9. doi: 10.1007/s10620-025-09597.
    PubMed     Abstract available


  27. DESAI A, Kochhar GS, Khataniar H, Hashash JG, et al
    Risk of Incident Immune-Mediated Inflammatory Diseases with Second Tumor Necrosis Factor Inhibitor Versus Alternative Biologic Therapy in Patients with Inflammatory Bowel Disease and First TNFi Exposure: A Real-World Cohort Study.
    Dig Dis Sci. 2025 Dec 9. doi: 10.1007/s10620-025-09598.
    PubMed     Abstract available


  28. GORE E, Femino C, Aronskyy I, Miller A, et al
    Correction: The Patient Experience with Point-of-Care Intestinal Ultrasound for Inflammatory Bowel Disease Monitoring: A Multicenter Study.
    Dig Dis Sci. 2025 Dec 6. doi: 10.1007/s10620-025-09542.
    PubMed    


  29. NAPOLITANO D, Bozzetti M, Petrosino F, Cilluffo S, et al
    Self-Efficacy as a Mediator Between Caregiver Burden, Health Literacy, and Contribution to Self-Care in Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Dec 3. doi: 10.1007/s10620-025-09577.
    PubMed     Abstract available


  30. AL TA'ANI O, Alsakarneh S, Shaukat A, Farraye FA, et al
    Risk of Intestinal and Extraintestinal Malignancies in Inflammatory Bowel Disease With and Without Primary Sclerosing Cholangitis.
    Dig Dis Sci. 2025 Dec 2. doi: 10.1007/s10620-025-09593.
    PubMed     Abstract available


  31. XU S, Zhang P, Li N, Liu J, et al
    IFX Is Associated with Higher Rates of 2-Year Mucosal Healing in Biologic-Naive CD Patients Compared to UST.
    Dig Dis Sci. 2025;70:4235-4246.
    PubMed     Abstract available


    November 2025
  32. SATO T, Takeuchi J, Nagase K, Shiraishi T, et al
    Initial Treatment Failure as a Predictor of Proximal Extension in Patients with Newly Diagnosed Limited Ulcerative Colitis: A Retrospective Cohort Study with Propensity Score-Matched Analysis.
    Dig Dis Sci. 2025 Nov 28. doi: 10.1007/s10620-025-09561.
    PubMed     Abstract available


  33. ZHANG S, Gu Y
    Walking on a Tightrope: Ulcerative Colitis Complicated by Clostridioides difficile Infection.
    Dig Dis Sci. 2025 Nov 25. doi: 10.1007/s10620-025-09582.
    PubMed    


  34. LUO M, Li Z, Cai L, Bu S, et al
    A Rare Extraintestinal Manifestation of Ulcerative Colitis.
    Dig Dis Sci. 2025 Nov 23. doi: 10.1007/s10620-025-09562.
    PubMed    


  35. MIYATANI Y, Choi D, Aronsohn AI, Pillai A, et al
    Safety and Efficacy of Upadacitinib in Patients with Inflammatory Bowel Disease After Liver Transplantation: A Case Series.
    Dig Dis Sci. 2025 Nov 20. doi: 10.1007/s10620-025-09569.
    PubMed     Abstract available


  36. ZHONGCHENG L, Bo P, Dongting C, Kang C, et al
    Endoscopic Treatment for Crohn's Disease-Related Deep Small Intestinal Strictures: Balloon-Assisted Enteroscopy-Guided Stricturotomy Versus Balloon Dilation Therapy-A Single-Center Retrospective Study.
    Dig Dis Sci. 2025 Nov 14. doi: 10.1007/s10620-025-09529.
    PubMed     Abstract available


  37. ABUBASHEER TM, Saad K, Altaweel A, Alomari O, et al
    Systematic Review of Bile Acids Metabolism in Crohn's Disease: Implications for Pathogenesis and Therapeutic Interventions.
    Dig Dis Sci. 2025 Nov 12. doi: 10.1007/s10620-025-09557.
    PubMed     Abstract available


  38. MEDAWAR E, Chin Koon Siw K, Zoughlami A, Ekhdoura M, et al
    Fistula Outcomes After Seton Removal in Patients with Perianal Fistulizing Crohn's Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2025 Nov 11. doi: 10.1007/s10620-025-09555.
    PubMed     Abstract available


  39. SAHYOUN LC, Gaidos JKJ
    Weighing In: The Use of Glucagon-Like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Nov 11. doi: 10.1007/s10620-025-09515.
    PubMed    


  40. VAN LIEROP LMA, Hoentjen F
    Incidental Inflammatory Bowel Disease: Is Surveillance and Treatment Needed?
    Dig Dis Sci. 2025 Nov 5. doi: 10.1007/s10620-025-09524.
    PubMed    


    October 2025
  41. WU Z, Sun X, Li B, Xie Z, et al
    Shared Biomarkers LCN2 and CXCL11 for Ulcerative Colitis and Colon Cancer: Bioinformatics Analysis and Diagnostic Model Construction.
    Dig Dis Sci. 2025 Oct 14. doi: 10.1007/s10620-025-09443.
    PubMed     Abstract available


  42. SEVIM R, Erhan S, Matur E
    MicroRNAs as Key Modulators of Intestinal Barrier Function: Pattern Recognition Receptors, Epithelial Junctional Complexes, and Therapeutic Approaches.
    Dig Dis Sci. 2025;70:3206-3228.
    PubMed     Abstract available


    September 2025
  43. JAMAL F, Odeh NB, Alatout MHI, Khan MA, et al
    Diet in Ulcerative Colitis: A Narrative Review of Its Role in Pathogenesis and Treatment.
    Dig Dis Sci. 2025 Sep 22. doi: 10.1007/s10620-025-09387.
    PubMed     Abstract available


  44. BRONZE S, Shenoy S, Agrawal M, Polydorides AD, et al
    Prevalence and Clinical Features of Incidental Inflammatory Bowel Disease Identified During Screening and Surveillance Colonoscopy.
    Dig Dis Sci. 2025 Sep 19. doi: 10.1007/s10620-025-09400.
    PubMed     Abstract available


  45. GORE E, Femino C, Aronskyy I, Miller A, et al
    The Patient Experience with Point-of-Care Intestinal Ultrasound for Inflammatory Bowel Disease Monitoring: A Multicenter Study.
    Dig Dis Sci. 2025 Sep 18. doi: 10.1007/s10620-025-09390.
    PubMed     Abstract available


  46. SACHAR M, Rojanasopondist P, Beaty W, Fernandez C, et al
    Safety and Efficacy of Ustekinumab and Vedolizumab Among Older Adults with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Sep 16. doi: 10.1007/s10620-025-09395.
    PubMed     Abstract available


  47. NGUYEN B, Quon S
    Is Inflammatory Bowel Disease a Risk Factor for Perforation During Diagnostic Colonoscopy? A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2025 Sep 13. doi: 10.1007/s10620-025-09392.
    PubMed     Abstract available


  48. KUCHA P, Rawa T, Kiljan J, Zagorowicz E, et al
    Severe Primary Epstein-Barr Virus Infection in a Young Female with Crohn's Disease Treated with Upadacitinib.
    Dig Dis Sci. 2025 Sep 13. doi: 10.1007/s10620-025-09391.
    PubMed    


  49. LUO M, Ye L, Ju J, Li Z, et al
    Rectal Metastasis Mimicking Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Sep 13. doi: 10.1007/s10620-025-09381.
    PubMed    


  50. YANG X, Xie F
    Clinical Insights on "Tolerability and Effectiveness of Glucagon?Like Peptide?1 Receptor Agonists in Patients with Inflammatory Bowel Disease".
    Dig Dis Sci. 2025 Sep 6. doi: 10.1007/s10620-025-09349.
    PubMed    


  51. ISHIDA N, Sugimoto K
    Annual Infliximab Monitoring After Treatment Optimization.
    Dig Dis Sci. 2025;70:2944-2946.
    PubMed     Abstract available


  52. WANG C, Lv G, Chen E, Xue Y, et al
    Cross-Trait Cross-Genome Cross-Organ Analysis of Gastrointestinal Disorders and Depression.
    Dig Dis Sci. 2025;70:3021-3033.
    PubMed     Abstract available


    August 2025
  53. DAI F, Ye S, Zhu Y, Zhang J, et al
    Identification of Inflammation-Related Diagnostic Biomarker and Molecular Subtypes in Ulcerative Colitis Based on Machine Learning.
    Dig Dis Sci. 2025 Aug 26. doi: 10.1007/s10620-025-09312.
    PubMed     Abstract available


  54. WENG J, Alizadeh M, Friedman S
    Glucagon-Like Peptide-1 Receptor Agonist Therapy Does Not Increase Gastrointestinal Adverse Events in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Aug 19. doi: 10.1007/s10620-025-09344.
    PubMed     Abstract available


  55. MENCHEN L
    Gaining the Upper Hand - Upadacitinib for Crohn's Disease with Ileostomy: A Real-World Gap Addressed.
    Dig Dis Sci. 2025 Aug 14. doi: 10.1007/s10620-025-09313.
    PubMed    


  56. STAMMERS M, Sartain S, Cummings JRF, Kipps C, et al
    Identification of Cohorts with Inflammatory Bowel Disease Amidst Fragmented Clinical Databases via Machine Learning.
    Dig Dis Sci. 2025 Aug 13. doi: 10.1007/s10620-025-09323.
    PubMed     Abstract available


  57. REHMAT M, Ul Haq U, Saddique MN, Mehmood L, et al
    Efficacy of Whole-Food Based Anti-inflammatory Dietary Interventions in the Management of Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2025 Aug 12. doi: 10.1007/s10620-025-09332.
    PubMed     Abstract available


  58. ANDERS-RUMSEY J, Kasmikha L, Chiang M, Hodish G, et al
    Inflammatory Bowel Disease Self-Care Behaviors in Context of Psychosocial Factors.
    Dig Dis Sci. 2025 Aug 12. doi: 10.1007/s10620-025-09326.
    PubMed     Abstract available


  59. BUTNARIU M
    Exercising Options: Personalized Exercise Program Improves Fatigue and Quality of Life Scores in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Aug 9. doi: 10.1007/s10620-025-09315.
    PubMed    


  60. CHAMAN LAL K, Zia Z, Naveed M, Khan M, et al
    Comment on "Clinical, Radiological and Pharmacokinetic Data of CT?P13 Subcutaneous in Individuals with Fistulizing Anoperineal Crohn's Disease".
    Dig Dis Sci. 2025 Aug 5. doi: 10.1007/s10620-025-09311.
    PubMed    


    July 2025
  61. FATHALLAH N, Draullette M, Kirchgesner J, Paul S, et al
    Clinical, Radiological and Pharmacokinetic Data of CT-P13 Subcutaneous in Individuals with Fistulizing Anoperineal Crohn's Disease.
    Dig Dis Sci. 2025 Jul 25. doi: 10.1007/s10620-025-09210.
    PubMed     Abstract available


  62. DEVI J, Jena A, Hassan A, Lohia R, et al
    Global Training in Inflammatory Bowel Disease: Addressing Growing Challenges in IBD.
    Dig Dis Sci. 2025 Jul 24. doi: 10.1007/s10620-025-09263.
    PubMed     Abstract available


  63. VALLE NP, Hamidi S, Rodriguez F, Limketkai BN, et al
    Correction: Cerebral Crohn's Disease-Not Your Typical Brain-Gut Connection.
    Dig Dis Sci. 2025 Jul 18. doi: 10.1007/s10620-025-09253.
    PubMed    


  64. ALIZADEH M, Cross RK, Cohen E
    Nervous Breakdown: Chronic Inflammatory Demyelinating Polyneuropathy as an Extra-Intestinal Manifestation of Ulcerative Colitis.
    Dig Dis Sci. 2025 Jul 12. doi: 10.1007/s10620-025-09184.
    PubMed    


  65. WANG G, Ching C, Hanna Y, Tandon P, et al
    Health Maintenance and Unique Health Needs of the Perimenopausal and Postmenopausal Woman with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Jul 8. doi: 10.1007/s10620-025-09199.
    PubMed     Abstract available


  66. SMYTH MJ, Dolinger MT, Kellar A, Spencer EA, et al
    Sonographic Transmural Induction Outcomes Across Advanced Therapies in Crohn's Disease.
    Dig Dis Sci. 2025 Jul 6. doi: 10.1007/s10620-025-09181.
    PubMed     Abstract available


  67. ZHANG P, Xu S, Li N, Yu C, et al
    Faecalibacterium prausnitzii Ameliorates DSS-Induced Colitis via Modulating Bile Acid Metabolism and Regulating FXR Signaling.
    Dig Dis Sci. 2025 Jul 5. doi: 10.1007/s10620-025-09176.
    PubMed     Abstract available


  68. ZHU D, Chen X
    Identification and Confirmation of Shared Etiology and Hub Biomarkers in Nonalcoholic Steatohepatitis and Crohn's Disease.
    Dig Dis Sci. 2025 Jul 1. doi: 10.1007/s10620-025-09190.
    PubMed     Abstract available


  69. FORBES AJ, Frampton CMA, Day AS, Gearry RB, et al
    20-Year Mortality in a Population-Based Cohort of Patients with Inflammatory Bowel Disease from New Zealand.
    Dig Dis Sci. 2025 Jul 1. doi: 10.1007/s10620-025-09180.
    PubMed     Abstract available


    June 2025
  70. ZHOU P, Fu Y, Lu J, Liu Y, et al
    Crohn's Disease Combined with Complex Anal Fistula and Anorectal Stenosis.
    Dig Dis Sci. 2025 Jun 28. doi: 10.1007/s10620-025-09192.
    PubMed    


  71. IYENGAR M, Jain A, Herfarth HH, Long MD, et al
    MUSings on a Crohn's Disease Diagnosis.
    Dig Dis Sci. 2025 Jun 26. doi: 10.1007/s10620-025-09160.
    PubMed    


  72. CLARKE LM, Gupta S, Winter HS, Ryan DP, et al
    Sound of Success: Intestinal Ultrasound in the Management of Refractory Stricturing Crohn's Disease.
    Dig Dis Sci. 2025 Jun 25. doi: 10.1007/s10620-025-09172.
    PubMed     Abstract available


  73. BORRAS-BLASCO J, Valcuende-Rosique A, Cornejo S
    Comment on "Switching to Subcutaneous Infliximab Maintenance Therapy is Effective in Patients with Inflammatory Bowel Disease".
    Dig Dis Sci. 2025 Jun 23. doi: 10.1007/s10620-025-09171.
    PubMed    


  74. SODERHOLM JD
    Adding Fat to the Fire: Does Lipidated IL-22 Promote Mucosal Healing in Patients with Inflammatory Bowel Disease Treated with Immunomodulators?
    Dig Dis Sci. 2025 Jun 23. doi: 10.1007/s10620-025-09169.
    PubMed    


  75. HAYEK ME, Chehade NEH, Mourad FH, Shen B, et al
    Radiation Therapy for Abdominal or Pelvic Cancer Treatment in Patients with Inflammatory Bowel Disease: A Systematic Review.
    Dig Dis Sci. 2025 Jun 17. doi: 10.1007/s10620-025-09128.
    PubMed     Abstract available


  76. LOEB L, Farraye FA, Crosby S, Loftus EV Jr, et al
    Patients with Crohn's Disease and Ileostomy Can Respond to Upadacitinib.
    Dig Dis Sci. 2025 Jun 14. doi: 10.1007/s10620-025-09125.
    PubMed     Abstract available


  77. VALLE NP, Hamidi S, Rodriguez F, Limketkai BN, et al
    Cerebral Crohn's Disease-Not Your Typical Brain-Gut Connection.
    Dig Dis Sci. 2025 Jun 13. doi: 10.1007/s10620-025-09150.
    PubMed    


  78. MATAR A, Abdelnaem N, Camilleri M
    Bone Broth Benefits: How Its Nutrients Fortify Gut Barrier in Health and Disease.
    Dig Dis Sci. 2025;70:1951-1961.
    PubMed     Abstract available


  79. STOY S, D'Alessio S, Sandahl TD, Dige A, et al
    Lipidated IL-22 Alone or Combined with Immunomodulatory Agents Improves Disease Endpoints and Promotes Mucosal Healing in a Mouse Model of Chronic Dextran Sodium Sulfate-Induced Colitis.
    Dig Dis Sci. 2025;70:2021-2031.
    PubMed     Abstract available


    May 2025
  80. CHAEMSUPAPHAN T, Limsrivilai J
    Ustekinumab Dose Optimization in Ulcerative Colitis: Is More Always Better?
    Dig Dis Sci. 2025 May 31. doi: 10.1007/s10620-025-09108.
    PubMed    


  81. OBAIDULLAH Z, Hassan MB, Fatima M, Kumar A, et al
    Adipokine Profiles and Their Association with Body Composition and Disease Activity in Pediatric Crohn's Disease.
    Dig Dis Sci. 2025 May 22. doi: 10.1007/s10620-025-09104.
    PubMed    


  82. O'DONNELL JEM, Leach ST, Bowcock NL, Chen S, et al
    Correction: Daily Vitamin D3 Versus Stoss Vitamin D3 for Correction of 25OHD Deficiency in Children with Inflammatory Bowel Disease, a Randomised Controlled Trial.
    Dig Dis Sci. 2025 May 19. doi: 10.1007/s10620-025-09061.
    PubMed    


  83. FEAGINS LA, Reveles KR
    Weighing the Consequences: Can Patients with Inflammatory Bowel Disease Jump on the GLP-1 Bandwagon?
    Dig Dis Sci. 2025 May 17. doi: 10.1007/s10620-025-09088.
    PubMed    


  84. LIU GXH, Day AS
    Alpha Fail: Ustekinumab to the Rescue After TNFalpha Failure in Patients with Moderate to Severe Crohn's Disease.
    Dig Dis Sci. 2025 May 10. doi: 10.1007/s10620-025-09090.
    PubMed    


  85. OWAIS M, Malani AK, Ameer F, Siddique A, et al
    Comments on "Evaluation of an Exercise Program in Patients with Inflammatory Bowel Disease: A Pilot Study".
    Dig Dis Sci. 2025 May 2. doi: 10.1007/s10620-025-09085.
    PubMed    


    April 2025
  86. BAHIRWANI J, Elmer J, Eskarous H, Jai Kumar Ahuja S, et al
    Frailty Prevalence and Evaluation of the FRAIL Scale Questionnaire in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Apr 29. doi: 10.1007/s10620-025-09073.
    PubMed     Abstract available


  87. LIM Y, Park B, Jeon K, Jeong OS, et al
    Annual Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease During Infliximab Maintenance Therapy: Balancing Efficacy with Risk of Pharmacokinetic Failure.
    Dig Dis Sci. 2025 Apr 29. doi: 10.1007/s10620-025-09032.
    PubMed     Abstract available


  88. MAGEN-RIMON R, Cohen M, Rosen I, Spector-Cohen I, et al
    Adipokine Profiles and Their Association with Body Composition and Disease Activity in Pediatric Crohn's Disease.
    Dig Dis Sci. 2025 Apr 29. doi: 10.1007/s10620-025-08941.
    PubMed     Abstract available


  89. ZHANG D, Sun Y, Wang J
    Transanal Opening of the Intersphincteric Space (TROPIS): Combined with Suture-Dragging for Treating of Rectovaginal and Perianal Fistulas in Crohn's Disease with Anorectal Stricture.
    Dig Dis Sci. 2025 Apr 28. doi: 10.1007/s10620-025-09059.
    PubMed    


  90. ZHENG W, Kiran RP, Shen B
    Endoscopic Therapy for Anastomotic Bleeding in Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Apr 25. doi: 10.1007/s10620-025-09029.
    PubMed     Abstract available


  91. PARK J, Kim S, Im JP, Lee HJ, et al
    Clinical Outcome of Inflammatory Bowel Disease with Clostridioides difficile Polymerase Chain Reaction Toxin-Positive/Enzyme Immunoassay Toxin-Negative: A Retrospective Cohort Study.
    Dig Dis Sci. 2025 Apr 21. doi: 10.1007/s10620-025-09045.
    PubMed     Abstract available


  92. SETHI S, Puri R, Jain HP, Ashwin DK, et al
    A Rare Cause of Terminal Ileal Ulcer: Beyond Tuberculosis and Crohn's Disease.
    Dig Dis Sci. 2025 Apr 18. doi: 10.1007/s10620-025-09023.
    PubMed    


  93. VAN DE POL N, Visser EH, van Noord D, van der Woude CJ, et al
    Evaluation of an Exercise Program in Patients with Inflammatory Bowel Disease: A Pilot Study.
    Dig Dis Sci. 2025 Apr 17. doi: 10.1007/s10620-025-09030.
    PubMed     Abstract available


  94. OOMKENS D, Mujagic Z, de Vries A, van der Meulen-de Jong A, et al
    Obesity Is Associated with Inferior Clinical Treatment Outcomes in Inflammatory Bowel Disease: A Nationwide Dutch Registry Study.
    Dig Dis Sci. 2025 Apr 16. doi: 10.1007/s10620-025-09052.
    PubMed     Abstract available


  95. SAWAF B, Abbarh S, Alsoud D
    Mirikizumab for Ulcerative Colitis: A Game-Changer or Just Another Incremental Advance?
    Dig Dis Sci. 2025 Apr 16. doi: 10.1007/s10620-025-09047.
    PubMed    


  96. ALSAKARNEH S, Camilleri M, Farraye FA, Hashash JG, et al
    Comparative Effectiveness of Bile Acid Sequestrants and Antibiotics in the Management of Acute Pouchitis: A Matched Cohort Study from the United States.
    Dig Dis Sci. 2025 Apr 16. doi: 10.1007/s10620-025-09039.
    PubMed     Abstract available


  97. VLADIMIROVA N, Zhao M, Ornbjerg LM, Moller JM, et al
    Musculoskeletal Symptoms and Clinical Findings in Bio-naive Patients with Inflammatory Bowel Disease Prior to Biological Treatment Initiation: A Prospective Cohort Study.
    Dig Dis Sci. 2025 Apr 15. doi: 10.1007/s10620-025-09016.
    PubMed     Abstract available


  98. ABDELMEGUID A, El Banna AA, Elsheikh W, Ellakany AI, et al
    Evaluation of Acute Severe Ulcerative Colitis Predictors for Steroid Therapy Refractoriness.
    Dig Dis Sci. 2025 Apr 5. doi: 10.1007/s10620-025-08982.
    PubMed     Abstract available


  99. TOMASIC V
    Seeing Is Believing: Does Red Dichromatic Imaging (RDI) Predict Histological Remission and Clinical Outcomes in Ulcerative Colitis Patients?
    Dig Dis Sci. 2025 Apr 3. doi: 10.1007/s10620-025-09027.
    PubMed    


  100. POSTILL G, Im JHB, Tang F, Benchimol EI, et al
    Unmet Healthcare Needs Among People with Inflammatory Bowel Disease: A Canadian Cross-Sectional Population-Representative Study.
    Dig Dis Sci. 2025 Apr 2. doi: 10.1007/s10620-025-09015.
    PubMed     Abstract available


  101. MULANAX C, Velayos FS
    Acute Severe Ulcerative Colitis in the Modern Era Spotlight on Opioids, Small Molecule Therapy, and Interdisciplinary Communication.
    Dig Dis Sci. 2025 Apr 2. doi: 10.1007/s10620-025-08947.
    PubMed    


  102. LIAVA C, Chourmouzi D, Sinakos E, Dimitroulas T, et al
    Prevalence, Clinical Features, and Extraintestinal Manifestations in Patients with Familial Inflammatory Bowel Diseases.
    Dig Dis Sci. 2025;70:1467-1476.
    PubMed     Abstract available


  103. HONAP S, Caron B, Ollech JE, Fischman M, et al
    Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International Study.
    Dig Dis Sci. 2025;70:1320-1327.
    PubMed     Abstract available


    March 2025
  104. LIN CJ, Chiang YC, Su TH, Shih IL, et al
    A Case of Uterine Adenosarcoma and Colonic Endometriosis Masquerading as Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Mar 21. doi: 10.1007/s10620-025-08988.
    PubMed     Abstract available


  105. DANPANICHKUL P, Pang Y, Vuthithammee C, Dejvajara D, et al
    Older Adults with Inflammatory Bowel Disease Epidemiology in the United States: 2000-2021.
    Dig Dis Sci. 2025 Mar 19. doi: 10.1007/s10620-025-08976.
    PubMed     Abstract available


  106. LATRAS-CORTES I, Saez Hortelano JC, Suarez-Alvarez P, Cano-Sanz N, et al
    Persistence and Efficacy of Ustekinumab in Crohn's Disease After Anti-TNF Failure: An Observational Study.
    Dig Dis Sci. 2025 Mar 19. doi: 10.1007/s10620-025-08978.
    PubMed     Abstract available


  107. VAN LIEROP LMA, Albino L, Rosentreter R, Thomas PWA, et al
    Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort Study.
    Dig Dis Sci. 2025 Mar 17. doi: 10.1007/s10620-025-08977.
    PubMed     Abstract available


  108. MOTWANI KK, Alizadeh M, Abutaleb A, Grossman J, et al
    Correction to: Correlation Between Serum and Fecal Biomarkers and Patient?Reported Outcomes in Patients with Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2025 Mar 13. doi: 10.1007/s10620-025-08963.
    PubMed    


  109. VERNON-ROBERTS A, Day AS
    Concise Commentary: Do Population Migrations Affect the Incidence, Severity, and Outcomes of Inflammatory Bowel Disease?
    Dig Dis Sci. 2025 Mar 12. doi: 10.1007/s10620-025-08972.
    PubMed    


  110. LIU Y, Sun Y, Zhou P, Wang J, et al
    Transanal Opening of the Intersphincteric Space (TROPIS) Combined with Suture-Dragging for Complex Rectovaginal Fistula (RVF) with Anorectal Stenosis in Crohn's Disease.
    Dig Dis Sci. 2025 Mar 12. doi: 10.1007/s10620-025-08967.
    PubMed    


  111. CLARKE L, Passam RT, Falahee B, Jirapinyo P, et al
    Tolerability and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Mar 11. doi: 10.1007/s10620-025-08964.
    PubMed     Abstract available


  112. BOURGONJE AR, Kayal M
    Understanding the Impact of Prior Anti-TNF Exposure on Colectomy Risk in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2025 Mar 6. doi: 10.1007/s10620-025-08930.
    PubMed    


  113. ST-PIERRE J, Choi D, Fear E, Choi NK, et al
    Mirikizumab in the Treatment of Ulcerative Colitis: Initial Real-World Data in a Population from a Large Tertiary Center.
    Dig Dis Sci. 2025 Mar 6. doi: 10.1007/s10620-025-08950.
    PubMed     Abstract available


  114. DAI C, Su XY
    Association Between Prior Anti-TNF Exposure and Colectomy in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2025 Mar 5. doi: 10.1007/s10620-025-08891.
    PubMed    


  115. MALIK S, Naqvi SAA, Shadali AH, Khan H, et al
    Fecal Microbiota Transplantation (FMT) and Clinical Outcomes Among Inflammatory Bowel Disease (IBD) Patients: An Umbrella Review.
    Dig Dis Sci. 2025 Mar 4. doi: 10.1007/s10620-025-08946.
    PubMed     Abstract available


  116. AHSAN M, Udaikumar J, Hong S, Faye AS, et al
    The Impact of Concomitant Hypothyroid Disease on the Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Mar 1. doi: 10.1007/s10620-025-08956.
    PubMed     Abstract available


  117. YOUSSEF M, Tandon P, Jones T, Srikanth V, et al
    Key Themes in the Care of Inflammatory Bowel Diseases Among Immigrant Populations: A Systematic Review.
    Dig Dis Sci. 2025;70:1016-1033.
    PubMed     Abstract available


  118. KAUNITZ JD
    Sometimes Small Is Beautiful: Discovery of the Janus Kinases (JAK) and Signal Transducer and Activator of Transcription (STAT) Pathways and the Initial Development of JAK Inhibitors for IBD Treatment.
    Dig Dis Sci. 2025;70:890-898.
    PubMed     Abstract available


  119. POWERS JC, Dester E, Schleicher M, Cohen B, et al
    Medical, Endoscopic, and Surgical Treatments for Rectal Cuffitis in IBD Patients with an Ileal Pouch-Anal Anastomosis: A Narrative Review.
    Dig Dis Sci. 2025;70:943-963.
    PubMed     Abstract available


  120. CLAYTOR JD, Lin DL, Magnaye KM, Guerrero YS, et al
    Effect of Fecal Microbiota Transplant on Antibiotic Resistance Genes Among Patients with Chronic Pouchitis.
    Dig Dis Sci. 2025;70:982-990.
    PubMed     Abstract available


    February 2025
  121. OWINGS AH, Glover SC, Cheifetz AS, Papamichael K, et al
    Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Feb 28. doi: 10.1007/s10620-025-08920.
    PubMed    


  122. O'DONNELL JEM, Leach ST, Bowcock NL, Chen S, et al
    Daily Vitamin D3 Versus Stoss Vitamin D3 for Correction of 25OHD Deficiency in Children with Inflammatory Bowel Disease, a Randomised Controlled Trial.
    Dig Dis Sci. 2025 Feb 28. doi: 10.1007/s10620-025-08913.
    PubMed     Abstract available


  123. CAVE DR, Hanscom M, Bledsoe J, Madahian S, et al
    Chronic Stenosing Enteritis: A Variant of Chronic Non-specific Stenosing Ulceration (CNSU) that Is Distinct from Crohn's Disease.
    Dig Dis Sci. 2025 Feb 22. doi: 10.1007/s10620-024-08815.
    PubMed     Abstract available


  124. SUN Y, Liu Y, Zhou P, Yang M, et al
    Transanal Opening of the Intersphincteric Space (TROPIS) for Managing High Complex Perianal Fistula in a Crohn's Disease Case with Anorectal Stenosis.
    Dig Dis Sci. 2025 Feb 18. doi: 10.1007/s10620-025-08859.
    PubMed    


  125. VASUDEVAN J, Mukkamala B, Dhother B, Guzik P, et al
    Delayed Corticosteroid Treatment for Patients Requiring Hospitalization for Acute Inflammatory Bowel Disease Exacerbations Increases Length of Stay and Risk for Surgery in Crohn's Disease.
    Dig Dis Sci. 2025 Feb 13. doi: 10.1007/s10620-025-08907.
    PubMed     Abstract available


  126. RAUTAKORPI J, Kolehmainen S, Loyttyniemi E, Bjorkesten CA, et al
    Switching to Subcutaneous Infliximab Maintenance Therapy Is Effective in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Feb 13. doi: 10.1007/s10620-025-08876.
    PubMed     Abstract available


  127. FANSIWALA K, Sauk JS
    Small Molecules, Big Results: How JAK Inhibitors Have Transformed the Treatment of Patients with IBD.
    Dig Dis Sci. 2025;70:469-477.
    PubMed     Abstract available


    January 2025
  128. MAMIYA Y, Taida T, Kato J, Matsusaka K, et al
    Usefulness of Novel Image-Enhanced Endoscopy for Predicting Maintenance of Clinical Remission in Ulcerative Colitis.
    Dig Dis Sci. 2025 Jan 27. doi: 10.1007/s10620-025-08849.
    PubMed     Abstract available


  129. WATSON KL JR
    Calling in Your Markers: Can Biomarkers Predict the Response to Anti-TNF Therapy in Pediatric Patients with Crohn's Disease?
    Dig Dis Sci. 2025 Jan 24. doi: 10.1007/s10620-025-08856.
    PubMed    


  130. TARASSISHIN L, Kim T, Hu J, Barre A, et al
    Elevated Fecal Lipocalin-2 Levels During Early Life Are Associated with Maternal Inflammatory Bowel Disease Diagnosis.
    Dig Dis Sci. 2025 Jan 24. doi: 10.1007/s10620-025-08864.
    PubMed     Abstract available


  131. KURIAKOSE KUZHIYANJAL AJ, Subramanian S, Limdi JK
    Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease-Perception and Reality.
    Dig Dis Sci. 2025 Jan 22. doi: 10.1007/s10620-025-08855.
    PubMed    


  132. KRISHNA M, Spartz EJ, Maas L, Cusumano V, et al
    Retrospective Cohort Study on the Predictive Value of Primary Non-response to Initial Biologic for Future Biologic Use in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Jan 4. doi: 10.1007/s10620-024-08816.
    PubMed     Abstract available


  133. JAVAID SS, Akhtar S, Hafeez A, Nofal A, et al
    Trends in Mortality Due to Inflammatory Bowel Disease in the United States: A CDC WONDER Database Analysis (1999-2020).
    Dig Dis Sci. 2025 Jan 2. doi: 10.1007/s10620-024-08803.
    PubMed     Abstract available


  134. FORBES AJ, Day AS, Frampton CMA, Gearry RB, et al
    Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand, 2018-2023.
    Dig Dis Sci. 2025 Jan 2. doi: 10.1007/s10620-024-08811.
    PubMed     Abstract available


  135. BOURGONJE AR, Posner H, Carbonnel F, Colombel JF, et al
    Prior Anti-TNF Exposure Is Associated with an Increased Risk of Short- and Long-Term Colectomy in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2025 Jan 2. doi: 10.1007/s10620-024-08809.
    PubMed     Abstract available


  136. SANDYS O, Stokkers PCF, Te Velde AA
    DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering.
    Dig Dis Sci. 2025;70:49-73.
    PubMed     Abstract available


    December 2024
  137. YANOVER C, Magen-Rimon R, Voss EA, Swerdel J, et al
    Characteristics and Outcomes of Over a Million Patients with Inflammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data Resource.
    Dig Dis Sci. 2024 Dec 26. doi: 10.1007/s10620-024-08787.
    PubMed     Abstract available


  138. DUPENLOUP P, Zhou M, Dizon MP, Shah AP, et al
    Therapeutic Drug Monitoring in Patients with Ulcerative Colitis on Infliximab: A Cost-Effectiveness Analysis.
    Dig Dis Sci. 2024 Dec 26. doi: 10.1007/s10620-024-08802.
    PubMed     Abstract available


  139. NARANG H, Kedia S
    Expanding Options for Endoscopic Therapy of Strictures in Patients with Inflammatory Bowel Disease: Is Stricturotomy the Best?
    Dig Dis Sci. 2024 Dec 13. doi: 10.1007/s10620-024-08726.
    PubMed    


    November 2024
  140. GALTS C, Siempelkamp B, Duthie K, Wilson L, et al
    Informing Modern Models of Care: A Randomized, Sequential Trial of In-Person, Telehealth, and Telephone Appointments for Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Nov 29. doi: 10.1007/s10620-024-08750.
    PubMed     Abstract available


  141. JIANG Y, Shi R, Zhou P, Lei Y, et al
    Application Value of Endoscopic Ultrasonography in Diagnosis and Treatment of Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Nov 29. doi: 10.1007/s10620-024-08751.
    PubMed     Abstract available


  142. LISAI-GOLDSTEIN Y, Focht G, Orlanski-Meyer E, Yogev D, et al
    Serological Markers as Predictors of Anti-TNF Response in Children with Crohn's Disease.
    Dig Dis Sci. 2024 Nov 27. doi: 10.1007/s10620-024-08732.
    PubMed     Abstract available


  143. YOUN J, Hsia K, Khadilkar S, Zeina T, et al
    The Impact of Obesity on the Prevalence and Complications of Perianal Fistulas of Crohn's Disease.
    Dig Dis Sci. 2024 Nov 16. doi: 10.1007/s10620-024-08729.
    PubMed     Abstract available


  144. SHEEHAN JL, Jordan AA, Newman KL, Johnson LA, et al
    Disparities in Vaccination Amongst Socially Vulnerable Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Nov 15. doi: 10.1007/s10620-024-08733.
    PubMed     Abstract available


  145. NIELSEN KR, Modin FA, Midjord J, Vang A, et al
    Comparing Environmental Risk Factors at Diagnosis in Faroese and Danish Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Nov 14. doi: 10.1007/s10620-024-08721.
    PubMed     Abstract available


  146. KLEMM N, Moosavi S
    Chronic Abdominal Pain in Patients with Inflammatory Bowel Disease in Remission: A Continuing Challenge for Clinicians.
    Dig Dis Sci. 2024 Nov 13. doi: 10.1007/s10620-024-08716.
    PubMed     Abstract available


  147. ST-PIERRE J, Klein J, Choi NK, Fear E, et al
    Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-diabetic Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Nov 8. doi: 10.1007/s10620-024-08720.
    PubMed     Abstract available


  148. VERNON-ROBERTS A, Blay L, Day AS
    Inflammatory Bowel Disease Knowledge and Education Among Healthcare Professional Groups.
    Dig Dis Sci. 2024 Nov 4. doi: 10.1007/s10620-024-08719.
    PubMed    


  149. EAR S, Cordero J, McConnell R, Velayos F, et al
    Extended Monitoring for Transition to Oral Corticosteroids in Acute Severe Ulcerative Colitis May Be Unnecessarily Prolonging Length of Stay.
    Dig Dis Sci. 2024 Nov 4. doi: 10.1007/s10620-024-08679.
    PubMed     Abstract available


    October 2024
  150. SHEEHAN JL, Greene-Higgs L, Resnicow K, Patel MR, et al
    Self-Efficacy, Patient Activation, and the Burden of Inflammatory Bowel Disease on Patients' Daily Lives.
    Dig Dis Sci. 2024 Oct 26. doi: 10.1007/s10620-024-08712.
    PubMed     Abstract available


  151. CHEN L, Peng J, Wang Y, Liu Y, et al
    FMT Combined with Vedolizumab for the Treatment of Refractory Ulcerative Colitis.
    Dig Dis Sci. 2024 Oct 26. doi: 10.1007/s10620-024-08666.
    PubMed    


  152. MEMEL Z, Thiemann A, Dort C, Mahadevan U, et al
    Prevalence of Malnutrition and Micronutrient Deficiencies in Older Adults with Ulcerative Colitis.
    Dig Dis Sci. 2024 Oct 22. doi: 10.1007/s10620-024-08650.
    PubMed     Abstract available


  153. FAN Y, Zhang L, Omidakhsh N, Bohn RL, et al
    Progression of Crohn's Disease in Newly Diagnosed Patients: Results from an Observational Study Using US Claims Data.
    Dig Dis Sci. 2024 Oct 22. doi: 10.1007/s10620-024-08591.
    PubMed     Abstract available


  154. DEMERS K, Bongers BC, van Kuijk SMJ, Plasqui G, et al
    Criterion Validity of Screening Tools and Field-Based Tests for Health-Related Physical Fitness in Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Oct 19. doi: 10.1007/s10620-024-08682.
    PubMed     Abstract available


  155. MOTWANI K, Cohen E, Liang JJ, Cross RK, et al
    Heartaches and Gut Feelings: Exploring Myocarditis in Crohn's Disease.
    Dig Dis Sci. 2024 Oct 12. doi: 10.1007/s10620-024-08674.
    PubMed    


  156. UKASHI O, Dotan A, Borkovsky T, Talan Asher A, et al
    Pro-motility Preparation Protocol May Reduce the Rates of Failed Patency Capsule Among Patients with Crohn's Disease in Clinical Remission.
    Dig Dis Sci. 2024 Oct 9. doi: 10.1007/s10620-024-08670.
    PubMed     Abstract available


  157. SHA L, Cao J, Yang Y, Wang J, et al
    5-Aminosalicylic Acid Aggravates Bloody Diarrhoea in Crohn's Disease.
    Dig Dis Sci. 2024 Oct 3. doi: 10.1007/s10620-024-08658.
    PubMed    


  158. YU X, Li C, Tao Y, Xia T, et al
    Lacidipine Inhibits NF-kappaB and Notch Pathways and Mitigates DSS-Induced Colitis.
    Dig Dis Sci. 2024;69:3753-3759.
    PubMed     Abstract available


  159. YE K, Jin Z, Chen Q, Cen L, et al
    Natural History and Longitudinal Outcomes of Patients with Mild-to-Moderate Ulcerative Proctitis or Ulcerative Proctosigmoiditis: A Single-Center, Retrospective Study.
    Dig Dis Sci. 2024;69:3701-3709.
    PubMed     Abstract available


    September 2024
  160. PRINCIPI M, Brescia IV, Stasi E, Mazzuoli S, et al
    Transition to Subcutaneous Infliximab vs Vedolizumab in Inflammatory Bowel Disease: A Prospective Multicenter Study.
    Dig Dis Sci. 2024 Sep 30. doi: 10.1007/s10620-024-08631.
    PubMed     Abstract available


  161. YANG JC, Zhao M, Chernikova D, Arias-Jayo N, et al
    ZIP8 A391T Crohn's Disease-Linked Risk Variant Induces Colonic Metal Ion Dyshomeostasis, Microbiome Compositional Shifts, and Inflammation.
    Dig Dis Sci. 2024 Sep 25. doi: 10.1007/s10620-024-08647.
    PubMed     Abstract available


  162. DRYGIANNAKIS I, Valatas V, Filidou E, Tzenaki N, et al
    Low-Grade Activation of the Extrinsic Coagulation Pathway in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2024 Sep 25. doi: 10.1007/s10620-024-08640.
    PubMed     Abstract available


  163. GONG Y, He Y, Wan M, Chen H, et al
    Risk Factors for Gallstones in Crohn's Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2024 Sep 25. doi: 10.1007/s10620-024-08597.
    PubMed     Abstract available


  164. ROMAIN D, Larson C, Kathuria P, Aintabi D, et al
    Understanding the Perspectives and Experiences of Patients with Acute Severe Ulcerative Colitis in the Hospital: A Qualitative Analysis.
    Dig Dis Sci. 2024 Sep 18. doi: 10.1007/s10620-024-08633.
    PubMed     Abstract available


  165. NEWLAND JJ, Sundel MH, Blackburn KW, Vessilenov R, et al
    Association of Race and Postoperative Outcomes in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Sep 11. doi: 10.1007/s10620-024-08594.
    PubMed     Abstract available


  166. ODAH T, Karime C, Desai A, Picco MF, et al
    Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib.
    Dig Dis Sci. 2024 Sep 9. doi: 10.1007/s10620-024-08630.
    PubMed     Abstract available


  167. ESCHER JC
    Transition or Transfer Readiness in Young Patients with IBD: What Does It Really Mean? : Invited commentary on Khan SM et al, A Smooth Transition: Assessing Transition Readiness In Adolescents with Inflammatory Bowel Disease (2024).
    Dig Dis Sci. 2024 Sep 9. doi: 10.1007/s10620-024-08624.
    PubMed    


  168. CLARKE LM, Riascos MC, Redston MS, Hamilton MJ, et al
    Ileal Signet Ring Adenocarcinoma in Crohn's Disease: Unanticipated Diagnosis After Surgical Resection of a Symptomatic Stricture.
    Dig Dis Sci. 2024 Sep 9. doi: 10.1007/s10620-024-08621.
    PubMed    


  169. GRAY C, Shakir R, Tumin D, Mandelia C, et al
    Predictors of Unplanned Health Care Utilization Among Children with Inflammatory Bowel Disease in a Rural Region of the Southeastern US.
    Dig Dis Sci. 2024 Sep 3. doi: 10.1007/s10620-024-08619.
    PubMed     Abstract available


  170. FORBES AJ
    Westernization and the Hazards of a "Taipei Personality"-Will the Incidence of IBD in Taiwan Catch Up with the West?
    Dig Dis Sci. 2024;69:3112-3113.
    PubMed    


  171. PAN Y, Lilly E, Ananthakrishnan AN
    Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2024;69:3375-3381.
    PubMed     Abstract available


  172. KUO CJ, Lin CY, Le PH, Kuo YW, et al
    Temporal Trends of Inflammatory Bowel Diseases in Taiwan from 2016 to 2020: A Population-Based Study.
    Dig Dis Sci. 2024;69:3172-3179.
    PubMed     Abstract available


    August 2024
  173. CHEN KA, Gartner V, Darlington KC, Silverstein SR, et al
    Post-operative Crohn's Disease Recurrence and Infectious Complications: A Transcriptomic Analysis.
    Dig Dis Sci. 2024 Aug 31. doi: 10.1007/s10620-024-08595.
    PubMed     Abstract available


  174. HARINDRANATH S
    Tofacitinib in Ulcerative Colitis - Second-Line Therapy, First-Rate Results.
    Dig Dis Sci. 2024 Aug 22. doi: 10.1007/s10620-024-08589.
    PubMed    


  175. HORIUCHI K, Higashiyama M, Tahara H, Yoshidome Y, et al
    Absence of Paneth Cell Metaplasia to Predict Clinical Relapse in Ulcerative Colitis with Endoscopically Quiescent Mucosa.
    Dig Dis Sci. 2024 Aug 7. doi: 10.1007/s10620-024-08581.
    PubMed     Abstract available


  176. HORWELL E, Vittoria M, Hong HA, Bearn P, et al
    A Family of Cyclic Lipopeptides Found in Human Isolates of Bacillus Ameliorates Acute Colitis via Direct Agonism of Toll-Like Receptor 2 in a Murine Model of Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Aug 7. doi: 10.1007/s10620-024-08534.
    PubMed     Abstract available


  177. ZHANG P, Zhang C, Chen B, He Y, et al
    Assessment of Endoscopy-Based Scoring Systems for Prognostication in Ulcerative Colitis: A Comparative Analysis.
    Dig Dis Sci. 2024 Aug 6. doi: 10.1007/s10620-024-08582.
    PubMed     Abstract available


  178. GNANAPANDITHAN K, Stuessel LG, Shen B, Mourad FH, et al
    Pelvic Radiation Therapy Increases Risk of Pouch Failure in Patients with Inflammatory Bowel Disease and Ileal Pouch.
    Dig Dis Sci. 2024 Aug 1. doi: 10.1007/s10620-024-08576.
    PubMed     Abstract available


  179. HSU WC, Chen CM, Kuo CJ, Tsou YK, et al
    Upper Gastrointestinal Involvement in Crohn's Disease as an Independent Predictor of New-Onset Strictures: Insights from an Extensive Retrospective Cohort Analysis.
    Dig Dis Sci. 2024 Aug 1. doi: 10.1007/s10620-024-08577.
    PubMed     Abstract available


  180. LOCKMAN S, Tandon P
    Low-Dose Aspirin Use in Pregnancy in Patients with IBD with Risk Factors for Preeclampsia: A Retrospective Cohort Study.
    Dig Dis Sci. 2024;69:2719-2720.
    PubMed    


  181. MAHMOUD M, Syn WK
    Impact of Obesity and Metabolic Syndrome on IBD Outcomes.
    Dig Dis Sci. 2024;69:2741-2753.
    PubMed     Abstract available


  182. ALPEREN CC, Soydas B, Serin E, Erbayrak M, et al
    Role of Environmental Risk Factors in the Etiology of Inflammatory Bowel Diseases: A Multicenter Study.
    Dig Dis Sci. 2024;69:2927-2936.
    PubMed     Abstract available


    July 2024
  183. SIFFLEDEEN J, Hoentjen F
    Disparities in Advanced Therapy Initiation for Inflammatory Bowel Disease: Access Comes First.
    Dig Dis Sci. 2024 Jul 29. doi: 10.1007/s10620-024-08580.
    PubMed    


  184. SWAMINATHAN A, Day AS
    Measures of Gut Inflammation in Patients with Inflammatory Bowel Disease: Are Blood-Based Biomarkers Sufficient?
    Dig Dis Sci. 2024 Jul 29. doi: 10.1007/s10620-024-08567.
    PubMed    


  185. COHEN-MEKELBURG S, Johnson J, Paine E, Prasad MA, et al
    Assessment of Physician Needs and Access to Inflammatory Bowel Disease Specialty Care Resources in a National Integrated Health System.
    Dig Dis Sci. 2024 Jul 27. doi: 10.1007/s10620-024-08560.
    PubMed     Abstract available


  186. MATHIEU K, Junda J, Minet-Quinard R, Coban D, et al
    Intestinal Ultrasonography as an Alternative to Fecal Calprotectin to Monitor Patients with Crohn's Disease: Experience from a Novice Sonographer.
    Dig Dis Sci. 2024 Jul 20. doi: 10.1007/s10620-024-08548.
    PubMed     Abstract available


  187. ABADIR A, Troia A, Said H, Tarugu S, et al
    Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Jul 4. doi: 10.1007/s10620-024-08514.
    PubMed     Abstract available


  188. MU J, Maeda K, Ohashi A, Urano T, et al
    Monoclonal Antibodies Against Mature Interleukin-18 Ameliorate Colitis and Repair Goblet Cell Function.
    Dig Dis Sci. 2024;69:2573-2585.
    PubMed     Abstract available


    June 2024
  189. JABER F, Numan L, Ayyad M, Abuelazm M, et al
    Efficacy and Safety of Endoscopic Stricturotomy in Inflammatory Bowel Disease-Related Strictures: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2024 Jun 26. doi: 10.1007/s10620-024-08533.
    PubMed     Abstract available


  190. ZHOU P, Lu J, Zhang J, Wang J, et al
    Perianal Fistulizing Crohn's Disease Combined with Pilonidal Sinus and Hidradenitis Suppurativa.
    Dig Dis Sci. 2024 Jun 26. doi: 10.1007/s10620-024-08535.
    PubMed    


  191. LEY D, Lazarus S, Forati AM, Farraye FA, et al
    High Rates of Seroprotection to Hepatitis B After a Hepatitis B Challenge Dose in Previously Vaccinated Patients with Inflammatory Bowel Disease on Immunosuppressive Therapy.
    Dig Dis Sci. 2024 Jun 21. doi: 10.1007/s10620-024-08527.
    PubMed     Abstract available


  192. ALIZADEH M, Wong U, Siaton BC, Patil SA, et al
    Inflammatory Bowel Disease-Associated Arthritis Is Associated with Concomitant Autoimmune and Inflammatory Disorders.
    Dig Dis Sci. 2024 Jun 20. doi: 10.1007/s10620-024-08478.
    PubMed     Abstract available


  193. TE VELDE AA
    Putting Crohn's Disease on the MAP: Potential Contribution of a "Stealth Pathogen".
    Dig Dis Sci. 2024 Jun 20. doi: 10.1007/s10620-024-08503.
    PubMed    


  194. AGRAWAL G, Borody TJ, Aitken JM
    Mapping Crohn's Disease Pathogenesis with Mycobacterium paratuberculosis: A Hijacking by a Stealth Pathogen.
    Dig Dis Sci. 2024 Jun 19. doi: 10.1007/s10620-024-08508.
    PubMed     Abstract available


  195. LOWELL JA, Sharma G, Chua V, Ben-Horin S, et al
    Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis.
    Dig Dis Sci. 2024 Jun 14. doi: 10.1007/s10620-024-08515.
    PubMed     Abstract available


  196. BARNES A, Mukherjee S, Andrews JM, Spizzo P, et al
    Active Inflammatory Bowel Disease Is Associated with Short Sleep Duration via Objective Measures.
    Dig Dis Sci. 2024 Jun 6. doi: 10.1007/s10620-024-08485.
    PubMed     Abstract available


  197. LORES T, Mikocka-Walus A, Andrews JM, Evans S, et al
    Psychological Care for People with Inflammatory Bowel Diseases: Exploring Consumers' Perspectives to Inform Future Service Co-design.
    Dig Dis Sci. 2024;69:1979-1989.
    PubMed     Abstract available


    May 2024
  198. JANAK JC, Loughlin AM, Moore PC, Lemay CA, et al
    The Burden of Work Productivity and Activity Impairment in Patients with Psoriasis, Psoriatic Arthritis, Ulcerative Colitis, and Crohn's Disease.
    Dig Dis Sci. 2024 May 29. doi: 10.1007/s10620-024-08451.
    PubMed     Abstract available


  199. COHEN NA, Choden T, Dyer EC, Garcia NM, et al
    Utility of the Endoscopic Healing Index in Identifying Active Inflammation in Patients with Crohn's Disease: Real World Data from a Tertiary Center.
    Dig Dis Sci. 2024 May 29. doi: 10.1007/s10620-024-08492.
    PubMed     Abstract available


  200. MOSKOW J, Thurston T, Saleh A, Shah A, et al
    Postoperative Ustekinumab Drug Levels and Disease Activity in Patients with Crohn's Disease.
    Dig Dis Sci. 2024 May 24. doi: 10.1007/s10620-024-08471.
    PubMed     Abstract available


  201. KHAN SM, Tuchman D, Imran A, Lakdawala FM, et al
    A Smooth Transition: Assessing Transition Readiness in Adolescents with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 May 23. doi: 10.1007/s10620-024-08484.
    PubMed     Abstract available


  202. MOTWANI KK, Alizadeh M, Abutaleb A, Grossman J, et al
    Correction to: Correlation Between Plasma and Fecal Biomarkers and Patient?Reported Outcomes in Patients with Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2024 May 16. doi: 10.1007/s10620-024-08469.
    PubMed    


  203. EMERSON C, Skvarc D, Mikocka-Walus A, Olive L, et al
    People with Inflammatory Bowel Disease Prefer Cognitive Behavioral Therapy for Fatigue Management: A Conjoint Analysis.
    Dig Dis Sci. 2024 May 11. doi: 10.1007/s10620-024-08468.
    PubMed     Abstract available


  204. MEDAWAR E, Djinbachian R, Crainic IP, Safih W, et al
    Serrated Polyps in Inflammatory Bowel Disease Indicate a Similar Risk of Metachronous Colorectal Neoplasia as in the General Population.
    Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08456.
    PubMed     Abstract available


  205. SCHREIBER S, Hunter Gibble T, Panaccione R, Rubin DT, et al
    Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study.
    Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08434.
    PubMed     Abstract available


  206. SIFFLEDEEN J, Singh S, Shulman SM, Igoe J, et al
    Effect of Suboptimal Disease Control on Patient Quality of Life: Real-World Data from the Observational IBD-PODCAST Canada Trial.
    Dig Dis Sci. 2024;69:1636-1648.
    PubMed     Abstract available


    April 2024
  207. GREYWOODE R, Larson J, Peraza J, Clark R, et al
    Risk of Adverse Cardiovascular Outcomes in Postmenopausal Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Apr 29. doi: 10.1007/s10620-024-08348.
    PubMed     Abstract available


  208. LAMICHHANE N, Melas N, Bergqvist V, Ekholm NP, et al
    Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Apr 18. doi: 10.1007/s10620-024-08422.
    PubMed     Abstract available


  209. KANE K, Velayos FS, Lee JK, Cherny S, et al
    A Response-able Diagnosis: Type 2 Autoimmune Pancreatitis in the Setting of Ulcerative Colitis.
    Dig Dis Sci. 2024 Apr 18. doi: 10.1007/s10620-024-08408.
    PubMed    


  210. VAN LINSCHOTEN RCA, Jansen FM, Pauwels RWM, Smits LJT, et al
    A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
    Dig Dis Sci. 2024 Apr 9. doi: 10.1007/s10620-024-08410.
    PubMed     Abstract available


  211. MOTWANI KK, Alizadeh M, Abutaleb A, Grossman J, et al
    Correlation Between Serum and Fecal Biomarkers and Patient-Reported Outcomes in Patients with Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08421.
    PubMed     Abstract available


  212. HARRIS S, Feagan BG, Hanauer S, Vermeire S, et al
    Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease.
    Dig Dis Sci. 2024 Apr 3. doi: 10.1007/s10620-024-08391.
    PubMed     Abstract available


  213. DJALAL A, Wong SY, Colombel JF, Ungaro R, et al
    Problem with Hookups: Perianal Fistula After Ileal Pouch-Anal Anastomosis.
    Dig Dis Sci. 2024;69:1102-1104.
    PubMed    


  214. CLINTON J, Motwani KK, Schwartz S, McCarthy P, et al
    Upadacitinib as Rescue Therapy for the Treatment of Acute Severe Colitis in an Acute Care Setting.
    Dig Dis Sci. 2024;69:1105-1109.
    PubMed     Abstract available


  215. SINGH A, Mahajan R, Midha V, Kaur K, et al
    Effectiveness of Tofacitinib in Ulcerative Proctitis Compared to Left Sided Colitis and Pancolitis.
    Dig Dis Sci. 2024;69:1389-1402.
    PubMed     Abstract available


    March 2024
  216. FIELD J, Shah ND, Memel Z, Mahadevan U, et al
    Exclusive Yet Effective: The Crohn's Disease Exclusion Diet as Treatment for Medication-Refractory Disease.
    Dig Dis Sci. 2024 Mar 30. doi: 10.1007/s10620-024-08345.
    PubMed    


  217. CARVALHAS GABRIELLI AM, Ferretti F, Monico CM, Tombetti E, et al
    Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study.
    Dig Dis Sci. 2024 Mar 26. doi: 10.1007/s10620-024-08394.
    PubMed     Abstract available


  218. KELLAR A, Dolinger MT, Spencer EA, Dubinsky MC, et al
    Real-World Outcomes of Dual Advanced Therapy in Children and Young Adults with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Mar 23. doi: 10.1007/s10620-024-08379.
    PubMed     Abstract available


  219. PEYRIN-BIROULET L, Bossuyt P, Bettenworth D, Loftus EV Jr, et al
    Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.
    Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-023-08252.
    PubMed     Abstract available


  220. DEBOLT CA, Gottlieb ZS, Rao MG, Johnson S, et al
    Low-Dose Aspirin Use Does Not Increase Disease Activity in Pregnant Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Mar 16. doi: 10.1007/s10620-024-08364.
    PubMed     Abstract available


  221. SAHYOUN LC, Fetene J, McMillan C, Protiva P, et al
    Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Mar 11. doi: 10.1007/s10620-024-08355.
    PubMed     Abstract available


  222. OLIVEIRA R, Martins V, de Sousa HT, Roseira J, et al
    Food-Related Quality of Life and Its Predictors in Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Mar 8. doi: 10.1007/s10620-024-08333.
    PubMed     Abstract available


  223. KOCHAR B, Rusher A, Araka E, Glasser R, et al
    Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2024;69:766-774.
    PubMed     Abstract available


  224. STALLMACH A, Grunert PC
    Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies.
    Dig Dis Sci. 2024;69:657-659.
    PubMed    


  225. VEGA P, Huguet JM, Gomez E, Rubio S, et al
    IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management.
    Dig Dis Sci. 2024;69:749-765.
    PubMed     Abstract available


    February 2024
  226. KOLOSKI N, Shah A, Kaan I, Ben Jacob R, et al
    Healthcare Utilization Patterns: Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Gastroesophageal Reflux Disease.
    Dig Dis Sci. 2024 Feb 24. doi: 10.1007/s10620-024-08297.
    PubMed     Abstract available


  227. SU W, Liang X, Lu H, Zhang J, et al
    Concurrent Arterial and Venous Thromboses in Ulcerative Colitis: A Complex Case of Multiorgan Involvement.
    Dig Dis Sci. 2024 Feb 20. doi: 10.1007/s10620-024-08268.
    PubMed    


  228. HUSSAIN N, Trivedi PJ
    Risk Stratification in Primary Sclerosing Cholangitis: Does Size Matter?
    Dig Dis Sci. 2024 Feb 12. doi: 10.1007/s10620-023-08262.
    PubMed    


  229. WEIDNER J
    IBD: Who Knows Best?
    Dig Dis Sci. 2024;69:324-325.
    PubMed    


    January 2024
  230. SINGH A, Bhardwaj A, Tripathi A, Ranjan MK, et al
    Burden of Anxiety, Depression and Perceived Stress in Patients with Inflammatory Bowel Disease: A Cohort Study from North India.
    Dig Dis Sci. 2024 Jan 28. doi: 10.1007/s10620-023-08242.
    PubMed     Abstract available


  231. EIDELBERG A, Axelrad J, Chedid V, Ballou S, et al
    Sexual Health in Sexual and Gender Minority Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Jan 24. doi: 10.1007/s10620-023-08253.
    PubMed     Abstract available


  232. MALIK A, Liu BD, Zhu L, Kaelber D, et al
    A Comprehensive Global Population-Based Analysis on the Coexistence of Eosinophilic Esophagitis and Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-024-08283.
    PubMed     Abstract available


  233. PARK J, Chun J, Park SJ, Park JJ, et al
    Effectiveness and Tolerability of Methotrexate Combined with Biologics in Patients with Crohn's Disease: A Multicenter Observational Study.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08237.
    PubMed     Abstract available


  234. ZHANG Y, Wang C, Wu L, Bai C, et al
    Epithelial CRL4(DCAF2) Is Critical for Maintaining Intestinal Homeostasis Against DSS-Induced Colitis by Regulating the Proliferation and Repair of Intestinal Epithelial Cells.
    Dig Dis Sci. 2024;69:66-80.
    PubMed     Abstract available


  235. PALLA AH
    Regular or DCAF2: How CRL4(DCAF2) Affects IBD-Related Mucosal Injury.
    Dig Dis Sci. 2024;69:3-4.
    PubMed    


  236. LEVITTE S
    Point-of-Care Assays for Infliximab Therapeutic Drug Monitoring in Patients with IBD: Is Quicker Better?
    Dig Dis Sci. 2024;69:5-6.
    PubMed    


    December 2023
  237. MIYATANI Y, Choi D, Choi NK, Rubin DT, et al
    Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease.
    Dig Dis Sci. 2023 Dec 19. doi: 10.1007/s10620-023-08182.
    PubMed     Abstract available


  238. VERNON-ROBERTS A, Blay L, Day AS
    Knowledge Levels About Inflammatory Bowel Disease Vary Between Healthcare Professional Groups.
    Dig Dis Sci. 2023 Dec 12. doi: 10.1007/s10620-023-08191.
    PubMed     Abstract available


  239. COHEN NA, Choi D, Garcia N, Choi NK, et al
    Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center.
    Dig Dis Sci. 2023 Dec 12. doi: 10.1007/s10620-023-08178.
    PubMed     Abstract available


  240. MASSIRONI S, Laffusa A, Parigi TL, Danese S, et al
    Standardizing Endoscopic Reporting in Patients with IBD: JEDII to the Rescue?
    Dig Dis Sci. 2023;68:4287-4289.
    PubMed    


  241. CONSTANT BD, Scott FI
    The PA System: Is Prior Authorization for Dose Escalation of IBD Biologic Therapy a Tolerable Alternative or a Perpetual Annoyance?
    Dig Dis Sci. 2023;68:4279-4281.
    PubMed    


    November 2023
  242. GU P, Dube S, Lee Y, Yang S, et al
    Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD).
    Dig Dis Sci. 2023 Nov 28. doi: 10.1007/s10620-023-08192.
    PubMed     Abstract available


  243. VALDES-DELGADO T, Aguado-Paredes A, Merino-Bohorquez V, Martin-Manzanares J, et al
    Performance of a New Rapid Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA.
    Dig Dis Sci. 2023 Nov 9. doi: 10.1007/s10620-023-08139.
    PubMed     Abstract available


    October 2023
  244. PIPICELLA JL, Vernon-Roberts A, Dutt S, Giles E, et al
    Co-design and Consultation Ensure Consumer Needs Are Met: Building an eHealth Platform for Children with Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Oct 28. doi: 10.1007/s10620-023-08146.
    PubMed     Abstract available


  245. BERINSTEIN EM, Sheehan JL, Jacob J, Steiner CA, et al
    Correction to: Efficacy and Safety of Dual Targeted Therapy for Partially or Non?responsive Inflammatory Bowel Disease: A Systematic Review of the Literature.
    Dig Dis Sci. 2023 Oct 27. doi: 10.1007/s10620-023-08130.
    PubMed    


  246. LAW CCY, Peraza J, Viera Feliciano N, Ungaro RC, et al
    Do We Need AI to Diagnose AI? Diagnosis and Management of Adrenal Insufficiency Following Steroid Therapy in a Patient with Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Oct 13. doi: 10.1007/s10620-023-08123.
    PubMed    


  247. MCCURDY JD, Chen JH, Golden S, Kukaswadia A, et al
    Perianal Fistulas Are Associated with Persistently Higher Direct Health Care Costs in Crohn's Disease: A Population-Based Study.
    Dig Dis Sci. 2023 Oct 5. doi: 10.1007/s10620-023-08096.
    PubMed     Abstract available


  248. PEREYRA L, Gomez EE, Gonzalez RA, Smolarczuk A, et al
    Impact of an Educational Mobile App on Inflammatory Bowel Disease Colonoscopy Report Quality.
    Dig Dis Sci. 2023 Oct 5. doi: 10.1007/s10620-023-08120.
    PubMed     Abstract available


  249. MAAS L, Gao R, Cusumano V, Spartz E, et al
    Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn's Perianal Fistulae.
    Dig Dis Sci. 2023;68:3994-4000.
    PubMed     Abstract available


    September 2023
  250. DUNLEAVY KA, Raffals LE, Camilleri M
    Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics.
    Dig Dis Sci. 2023 Sep 29. doi: 10.1007/s10620-023-08122.
    PubMed     Abstract available


  251. DALAL RS, Baranov E, Li J, Hong X, et al
    Small Cells, Big Problems: Small Cell Carcinoma of the Rectal Cuff After Ileal-Pouch Anal Anastomosis in a Patient with Ulcerative Colitis.
    Dig Dis Sci. 2023 Sep 22. doi: 10.1007/s10620-023-08110.
    PubMed    


  252. SHAH NB, Zuckerman AD, Hosteng KR, Fann J, et al
    Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Sep 19. doi: 10.1007/s10620-023-08098.
    PubMed     Abstract available


  253. COATES MD, Dalessio S, Walter V, Stuart A, et al
    Lifestyle Factors Associated with Abdominal Pain in Quiescent Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Sep 15. doi: 10.1007/s10620-023-08075.
    PubMed     Abstract available


  254. PERRY CL, Rhudy CN
    Urban Legend: Addressing Knowledge Gaps in Inflammatory Bowel Disease Epidemiology.
    Dig Dis Sci. 2023 Sep 15. doi: 10.1007/s10620-023-08073.
    PubMed    


  255. LIM J, Rezaie A
    Irritable Bowel Syndrome-Like Symptoms in Quiescent Inflammatory Bowel Disease: A Practical Approach to Diagnosis and Treatment of Organic Causes.
    Dig Dis Sci. 2023 Sep 11. doi: 10.1007/s10620-023-08095.
    PubMed     Abstract available


  256. MORTON H, Coad J, Pedley KC, Irwin JR, et al
    Incidence of Inflammatory Bowel Disease in New Zealand Remains High, Findings in the Manawatu Region.
    Dig Dis Sci. 2023 Sep 2. doi: 10.1007/s10620-023-08070.
    PubMed     Abstract available


    August 2023
  257. CHIOREAN M, Ha C, Hur P, Sharma PP, et al
    Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database.
    Dig Dis Sci. 2023 Aug 28. doi: 10.1007/s10620-023-08063.
    PubMed     Abstract available


  258. CUSHING K, Gudjonsson JE, Speliotes E, Higgins PDR, et al
    An Assessment of Comparative Medication Durability in Inflammatory Bowel Disease Patients With and Without Co-morbid Psoriasis, Rheumatoid Arthritis, and/or Enteropathic Arthritis.
    Dig Dis Sci. 2023 Aug 9. doi: 10.1007/s10620-023-08062.
    PubMed     Abstract available


  259. LI T, Click B, Bachour S, Sachs M, et al
    Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn's Disease.
    Dig Dis Sci. 2023 Aug 7. doi: 10.1007/s10620-023-08044.
    PubMed     Abstract available


  260. FUDMAN DI
    Monitoring Postoperative Crohn's Disease-Closing the Gap.
    Dig Dis Sci. 2023 Aug 7. doi: 10.1007/s10620-023-08051.
    PubMed    


    July 2023
  261. LEE DU, Menegas S, Lee KJ, Pu A, et al
    Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis.
    Dig Dis Sci. 2023 Jul 14. doi: 10.1007/s10620-023-08023.
    PubMed     Abstract available


  262. SLEIMAN J, Patel M, Khan MZ, Falloon K, et al
    Sweet Syndrome Associated with Active Inflammatory Bowel Disease: A Case Series of a Rare Extra-intestinal Manifestation.
    Dig Dis Sci. 2023 Jul 5. doi: 10.1007/s10620-023-07983.
    PubMed     Abstract available


  263. PATEL NB, Vinsard DG, Kattah AG, Kane SV, et al
    Decreased Risk of Preeclampsia in Women with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy.
    Dig Dis Sci. 2023 Jul 5. doi: 10.1007/s10620-023-08016.
    PubMed     Abstract available


  264. ESCKILSEN S, Kochar B, Weaver KN, Herfarth HH, et al
    Very Early Pouchitis Is Associated with an Increased Likelihood of Chronic Inflammatory Conditions of the Pouch.
    Dig Dis Sci. 2023;68:3139-3147.
    PubMed     Abstract available


  265. BIAN Z, Zhang Q, Qin Y, Sun X, et al
    Sodium Butyrate Inhibits Oxidative Stress and NF-kappaB/NLRP3 Activation in Dextran Sulfate Sodium Salt-Induced Colitis in Mice with Involvement of the Nrf2 Signaling Pathway and Mitophagy.
    Dig Dis Sci. 2023;68:2981-2996.
    PubMed     Abstract available


    June 2023
  266. VUYYURU SK, Solitano V, Hogan M, MacDonald JK, et al
    Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn's Disease: Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2023 Jun 28. doi: 10.1007/s10620-023-08014.
    PubMed     Abstract available


  267. TSE CS, Nguyen HP, Singh S, Dulai PS, et al
    Correlations Between Gastrointestinal Symptoms and Endoscopic-Histologic Disease Activity in Adults with Ulcerative Colitis.
    Dig Dis Sci. 2023 Jun 3. doi: 10.1007/s10620-023-07986.
    PubMed     Abstract available


  268. SALWEN-DEREMER JK, Godzik CM, Jagielski CH, Siegel CA, et al
    Patients with IBD Want to Talk About Sleep and Treatments for Insomnia with Their Gastroenterologist.
    Dig Dis Sci. 2023;68:2291-2302.
    PubMed     Abstract available


    May 2023
  269. KUANG R, Levinthal DJ, Ghaffari AA, Del Aguila de Rivers CR, et al
    Nightshade Vegetables: A Dietary Trigger for Worsening Inflammatory Bowel Disease and Irritable Bowel Syndrome?
    Dig Dis Sci. 2023 May 19. doi: 10.1007/s10620-023-07955.
    PubMed     Abstract available


  270. GOGOKHIA L, Lukin DJ
    PRO Tips: First-Rate Guidance for Second-Line Therapy After Tumor Necrosis Factor-Alpha Exposure in Patients with Crohn's Disease.
    Dig Dis Sci. 2023 May 5. doi: 10.1007/s10620-023-07941.
    PubMed    


  271. JANSEN FM, Smits LJT, Thomas PWA, de Jong DJ, et al
    Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy.
    Dig Dis Sci. 2023 May 2. doi: 10.1007/s10620-023-07950.
    PubMed     Abstract available


  272. KIM SY, Park JH, Leite G, Pimentel M, et al
    Interleukin-10 Knockout Mice Do Not Reliably Exhibit Macroscopic Inflammation: A Natural History Endoscopic Surveillance Study.
    Dig Dis Sci. 2023;68:1858-1862.
    PubMed     Abstract available


    April 2023
  273. WONG ECL, Merat S, Monaco C, Dulai PS, et al
    Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study.
    Dig Dis Sci. 2023 Apr 29. doi: 10.1007/s10620-023-07956.
    PubMed     Abstract available


  274. KAPPELMAN MD, Lewis JD, Zhang X, Lin FC, et al
    Comparing Patient-Reported Outcomes Among Anti-TNF-Experienced Patients with Crohn's Disease Initiating Vedolizumab Versus Ustekinumab.
    Dig Dis Sci. 2023 Apr 28. doi: 10.1007/s10620-023-07942.
    PubMed     Abstract available


  275. FANTASIA S, Cortegoso Valdivia P, Gaiani F
    Ileal Acute Diverticulitis Mimicking Crohn's Disease.
    Dig Dis Sci. 2023 Apr 28. doi: 10.1007/s10620-023-07954.
    PubMed    


  276. CHODEN T, Cohen RD
    Looking from the Past to the Future: How Janus Kinase Inhibitors Have Altered the Therapy of Ulcerative Colitis.
    Dig Dis Sci. 2023 Apr 8. doi: 10.1007/s10620-023-07933.
    PubMed    


  277. NELSON AD, Fluxa D, Caldera F, Farraye FA, et al
    Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Apr 7. doi: 10.1007/s10620-023-07920.
    PubMed     Abstract available


  278. DARLINGTON K, Googe P, Vedak P, Jain A, et al
    Lower Extremity Palpable Purpura in a Patient with Quiescent Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Apr 6. doi: 10.1007/s10620-023-07934.
    PubMed    


  279. ALMASRY M, Caldera F
    Taking a JAB at How Gastroenterologists Can Increase Vaccination Rates in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Apr 6. doi: 10.1007/s10620-023-07905.
    PubMed    


  280. PATEL J, Noureldin M, Fakhouri D, Farraye FA, et al
    Interventions Increase Vaccination Rates in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2023 Apr 6. doi: 10.1007/s10620-023-07903.
    PubMed     Abstract available


  281. COHEN NA, Steinberg JM, Silfen A, Traboulsi C, et al
    Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes.
    Dig Dis Sci. 2023;68:1464-1472.
    PubMed     Abstract available


  282. LIANG C, Tang Y, Gao X, Lei N, et al
    Depression Exacerbates Dextran Sulfate Sodium-Induced Colitis via IRF5-Mediated Macrophage Polarization.
    Dig Dis Sci. 2023;68:1269-1279.
    PubMed     Abstract available


  283. RAJBHANDARI R, Blakemore S, Gupta N, Mannan S, et al
    Crohn's Disease Among the Poorest Billion: Burden of Crohn's Disease in Low- and Lower-Middle-Income Countries.
    Dig Dis Sci. 2023;68:1226-1236.
    PubMed     Abstract available


    March 2023
  284. NOSER AE, Lancaster BD, Hommel KA, Roberts CM, et al
    Use of Behavior Change Techniques and Quality of Commercially Available Inflammatory Bowel Disease Apps.
    Dig Dis Sci. 2023 Mar 18. doi: 10.1007/s10620-023-07884.
    PubMed     Abstract available


  285. DALAL RS, Goksel B, Hamilton MJ
    Excipient Exception: A Complication of Infliximab and Vedolizumab Infusions for Ulcerative Colitis.
    Dig Dis Sci. 2023 Mar 17. doi: 10.1007/s10620-023-07866.
    PubMed    


  286. ERIKSSON C, Soderling J, Karlqvist S, Broms G, et al
    Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease.
    Dig Dis Sci. 2023 Mar 17. doi: 10.1007/s10620-023-07897.
    PubMed     Abstract available


  287. UNGARO RC, Naegeli AN, Choong CK, Shan M, et al
    Early Use of Biologics Reduces Healthcare Costs in Crohn's Disease: Results from a United States Population-Based Cohort.
    Dig Dis Sci. 2023 Mar 15. doi: 10.1007/s10620-023-07906.
    PubMed     Abstract available


  288. STRAATMIJER T, Biemans VBC, Moes DJAR, Hoentjen F, et al
    Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn's Disease.
    Dig Dis Sci. 2023 Mar 15. doi: 10.1007/s10620-023-07822.
    PubMed     Abstract available


  289. LEVITTE S, Peale FV, Jhun I, McBride J, et al
    Local Pentraxin-2 Deficit Is a Feature of Intestinal Fibrosis in Crohn's Disease.
    Dig Dis Sci. 2023 Mar 8. doi: 10.1007/s10620-023-07909.
    PubMed     Abstract available


  290. AHMED T, Kayal M, Hashem D, Ungaro RC, et al
    Besting the Biologics: Vancomycin Monotherapy for Ulcerative Colitis Management in Patients with Primary Sclerosing Cholangitis.
    Dig Dis Sci. 2023 Mar 7. doi: 10.1007/s10620-023-07826.
    PubMed    


  291. VELAYOS FS
    Rise over Runs: Elevated Creatinine and a New Diagnosis of Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Mar 7. doi: 10.1007/s10620-023-07852.
    PubMed    


  292. CONSTANT BD, de Zoeten EF, Weinman JP, Albenberg L, et al
    Early Anti-Tumor-Necrosis-Factor Therapy for Crohn's Disease-Related Abdominal Abscesses and Phlegmon in Children.
    Dig Dis Sci. 2023;68:877-888.
    PubMed     Abstract available


  293. AGGARWAL M, Garg R, Parthasarthy G, Nowacki AS, et al
    Crohn's Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2023;68:1006-1015.
    PubMed     Abstract available


  294. FRIEDBERG S, Hanan I, Hyman N, Rubio G, et al
    Ileal Desmoid Tumor in Ileal Crohn's: Coincidence or Connection?
    Dig Dis Sci. 2023;68:1071-1073.
    PubMed    


    February 2023
  295. MUBASHIR M, Carnell C, Haddadin I, Holubar SD, et al
    Refractory Ulcerative Colitis Requiring Preoperative Suction Thrombectomy of Submassive Bilateral Pulmonary Emboli Before Total Abdominal Colectomy.
    Dig Dis Sci. 2023 Feb 28. doi: 10.1007/s10620-023-07843.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum